U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07937592) titled 'Study the Mechanism and Effectiveness of Probiotics on Atopic Dermatitis' on Oct. 23.

Brief Summary: The goal of this clinical trial is to learn whether probiotics isolated from breast milk and healthy infant feces can reduce the severity of atopic dermatitis (eczema) in children aged 3 to 18 years with moderate-to-severe disease. The main questions it aims to answer are:

* Does taking the probiotic capsule twice daily for 12 weeks reduce eczema severity, measured by the EASI SCORAD?

* Does the probiotic improve quality of life, blood markers of allergic inflammation (IgE, histamine, IL-31, T-cell subsets), and gut microbiota comp...